Inhibition of AXL receptor tyrosine kinase enhances brown adipose tissue functionality in mice
Vissarion Efthymiou, Lianggong Ding, Miroslav Baláž, Wenfei Sun, Lucia Balážová, Leon G. Straub, Hua Dong, Eric J. Simon, Adhideb Ghosh, Aliki Perdikari, Svenja Aline Keller, Umesh Ghoshdastider, Carla Horváth, Caroline Moser, Bradford S. Hamilton, Heike Neubauer, Christian Wolfrum
Abstract
The current obesity epidemic and high prevalence of metabolic diseases necessitate efficacious and safe treatments. Brown adipose tissue in this context is a promising target with the potential to increase energy expenditure, however no pharmacological treatments activating brown adipose tissue are currently available. Here, we identify AXL receptor tyrosine kinase as a regulator of adipose function. Pharmacological and genetic inhibition of AXL enhance thermogenic capacity of brown and white adipocytes, in vitro and in vivo. Mechanistically, these effects are mediated through inhibition of PI3K/AKT/PDE signaling pathway, resulting in induction of nuclear FOXO1 localization and increased intracellular cAMP levels via PDE3/4 inhibition and subsequent stimulation of the PKA-ATF2 pathway. In line with this, both constitutive Axl deletion as well as inducible adipocyte-specific Axl deletion protect animals from diet-induced obesity concomitant with increases in energy expenditure. Based on these data, we propose AXL receptor as a target for the treatment of obesity.